ArticleMolecular genetics and metabolism reports2021

Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease.

Nathaniel Kleytman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.